NewEdge Advisors’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$647 Hold
176
﹤0.01% 4037
2026
Q1
$655 Buy
176
+1
+0.6% +$3 ﹤0.01% 3962
2025
Q4
$420 Hold
175
﹤0.01% 4084
2025
Q3
$999 Buy
175
+148
+548% +$1.14K ﹤0.01% 3877
2025
Q2
$116 Hold
27
﹤0.01% 3898
2025
Q1
$451 Hold
27
﹤0.01% 3725
2024
Q4
$528 Hold
27
﹤0.01% 3647
2024
Q3
$1.16K Hold
27
﹤0.01% 3488
2024
Q2
$2.06K Hold
27
﹤0.01% 3325
2024
Q1
$4.99K Buy
+27
New +$5.29K ﹤0.01% 3140

Other funds holding ICU

NewEdge Advisors's ICU Position: Q2 2026 in Review

NewEdge Advisors held its SeaStar Medical (ICU) position steady in Q2 2026 at 176 shares worth $647. The position accounts for ﹤0.01% of the portfolio, ranked #4037.

NewEdge Advisors first reported a position in ICU in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.99K in Q1 2024. 18 funds tracked by Wall St. Rank hold ICU as of Q2 2026.

  • NewEdge Advisors held 176 shares of SeaStar Medical worth $647 as of Q2 2026.
  • NewEdge Advisors left its SeaStar Medical share count unchanged in Q2 2026.
  • SeaStar Medical made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4037 holding.
  • NewEdge Advisors first reported a position in SeaStar Medical in Q1 2024 and has held it in 10 quarters since.
  • NewEdge Advisors's SeaStar Medical position peaked at $4.99K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.